allogeneic NK transfer immunotherapy / National University of Colombia - LARVOL DELTA

Adoptive Cell Transfer for the Immunotherapy of COVID-19 in Colombia (clinicaltrials.gov) - P1/2; N=0; Withdrawn; Sponsor: Universidad Nacional de Colombia; N=10 ➔ 0; Not yet recruiting ➔ Withdrawn

Clinical • Enrollment change • Trial withdrawal • Infectious Disease • Novel Coronavirus Disease

Phase I / II Clinical Study of Immunotherapy Based on Adoptive Cell Transfer as a Therapeutic Alternative for Patients With COVID-19 in Colombia (clinicaltrials.gov) - P1/2; N=10; Not yet recruiting; Sponsor: Universidad Nacional de Colombia

Clinical • New P1/2 trial • Infectious Disease • Novel Coronavirus Disease